ALTEOGEN Inc. (KOSDAQ:196170)
South Korea · Delayed Price · Currency is KRW 446,000
-7,000 (-1.55%)
Oct 24, 2025, 3:30 PM KST
ALTEOGEN Market Cap
ALTEOGEN has a market cap or net worth of 23.85 trillion as of October 24, 2025. Its market cap has increased by 27.20% in one year.
Market Cap
23.85T
Enterprise Value
23.60T
Revenue
158.06B
Ranking
n/a
PE Ratio
275.76
Stock Price
446,000.00
Market Cap Chart
Since December 12, 2014, ALTEOGEN's market cap has increased from 119.96B to 23.85T, an increase of 19,784.85%. That is a compound annual growth rate of 62.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 23.85T | 44.61% |
| Dec 30, 2024 | 16.49T | 221.05% |
| Dec 28, 2023 | 5.14T | 160.78% |
| Dec 29, 2022 | 1.97T | -38.41% |
| Dec 30, 2021 | 3.20T | -36.62% |
| Dec 30, 2020 | 5.05T | 442.81% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 83.84T |
| Celltrion | 38.09T |
| Yuhan | 8.54T |
| SK Biopharmaceuticals | 8.34T |
| Peptron | 6.00T |
| HLB Co., Ltd. | 5.98T |
| PharmaResearch | 5.69T |
| LigaChem Biosciences | 4.84T |